Naltrexone Tested as
Weight Gain Deterrent in Quitting Smoking
To find out more about our free research programs that can help you quit smoking call (203) 974-7588. Email infocentury@yale.edu
Yale researchers are investigating the use of the medication naltrexone to help men and women quit smoking without gaining weight.
“The prospect of gaining weight is of particular concern to women smokers and to a substantial number of men,” said Stephanie O'Malley, professor of psychiatry at Yale School of Medicine, director of the Substance Abuse Research Division, and principal investigator for the Yale Transdisciplinary Tobacco Use Research Center (TTURC). “The development of a treatment that will allow smokers to quit while reducing weight gain could convince more people to attempt quitting,” she said.
Naltrexone is a medication that blocks the effects of drugs such as morphine, heroin, and codeine. It also has been approved for use in treating alcoholism and is being investigating for its ability to help smokers quit.
She and her team are looking for men and women smokers who want to quit and are also concerned about gaining weight while doing so. All of the participants will use the nicotine patch and will receive counseling to help them quit. Some of the participants also will receive a low dose of naltrexone to see whether it has an effect on their weight and their ability to quit smoking. Most smoking studies provide treatment for six to 12 weeks. This study will provide nicotine replacement therapy for eight weeks and counseling for six months.
Dr. Benjamin Toll, associate research scientist, said most smokers gain weight in the first six months after quitting smoking. “Extending the traditional length of treatment might not only increase abstinence rates and prevent relapse, but also allow for greater stabilization of the person as a successful quitter,” Toll said.
Yale TTURC is part of the Center for Nicotine and Tobacco Use Research at Yale and is one of seven research centers nationwide conducting a diverse spectrum of transdisciplinary tobacco-related research. It is funded by the National Cancer Institute, the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, and The Robert Wood Johnson Foundation.
(HIC #
26956) |
